| Annual Financials | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 69 | 59 | 80 | 84 | 0 |
| Expenses | 54 | 53 | 56 | 55 | 0 |
| EBITDA | 15 | 6 | 24 | 29 | 0 |
| Operating Profit % | 21 % | 10 % | 29 % | 34 % | 0 % |
| Depreciation | 4 | 3 | 5 | 5 | 0 |
| Interest | 2 | 2 | 2 | 3 | 0 |
| Profit Before Tax | 9 | 1 | 16 | 21 | 0 |
| Tax | 3 | 0 | 4 | 6 | 0 |
| Net Profit | 6 | 1 | 13 | 16 | 0 |
| EPS in ₹ | 41.95 | 3.89 | 82.78 | 11.80 | 0.00 |
Star Imaging And Path Lab
Star Imaging And Path Lab
85.00
-1.00
(-1.16%)
Market Cap
148.06 Cr
PE Ratio
9.39
Volume
7,000.00
Day High - Low
87.25 - 82.75
52W High-Low
152.00 - 81.80
Key Fundamentals
Market Cap
148.06 Cr
EPS
11.80
PE Ratio
9.39
PB Ratio
1.46
Book Value
59.02
EBITDA
28.90
Dividend Yield
0.00 %
Industry
Healthcare Services Sector
Healthcare Service Provider Return on Equity
33.78
Debt to Equity
0.81
Actual
Company News
View All News
Star Imaging and Path Lab Limited secures approval to provide credit/cashless medical services to Supreme Court officials and their families under CGHS norms, expanding its healthcare service portfolio.
Star Imaging and Path Lab Reports 11% Revenue Growth in H1 FY2026Nov 13, 2025
Star Imaging and Path Lab Limited reported revenue from operations of Rs 4,519.14 lakhs for the half year ended September 30, 2025, compared to Rs 4,072.18 lakhs in the same period last year. The company's profit after tax increased to Rs 1,009.35 lakhs from Rs 971.52 lakhs in the previous year. Basic earnings per share stood at Rs 5.79. The company operates in diagnostic services and has utilized Rs 2,852.50 lakhs out of Rs 5,566.40 lakhs raised through its IPO for working capital requirements, loan repayment, medical equipment purchase, and corporate expenses. The Board of Directors approved these unaudited standalone and consolidated financial results in their meeting held on November 13, 2025.
Star Imaging and Path Lab Limited submitted its monitoring agency report for the quarter ended September 30, 2025, showing utilization of Rs. 17.38 crore from its Rs. 55.66 crore IPO proceeds. The company raised Rs. 49.67 crore in net proceeds after expenses. During the quarter, Rs. 4.84 crore was used for working capital requirements, Rs. 12.00 crore for loan repayments to various banks including Axis Bank, HDFC Bank, ICICI Bank, and Kotak Bank, and Rs. 0.54 crore for general corporate purposes including unsecured loan repayment. The remaining Rs. 32.29 crore is parked in fixed deposits and current accounts with HDFC Bank and Standard Chartered Bank. Infomerics Valuation and Rating Limited, the monitoring agency, reported no deviations from the objects stated in the offer document and confirmed all utilization was as per disclosed purposes.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,418.20 | #1 23,762.09 | 45.05 | #1 2,554.80 | 11.28 | #1 492 | 16.36 | 40.44 | |
993.20 | 10,202.64 | 68.32 | 699.70 | 23.06 | 144 | 2.85 | 40.89 | |
1,920.40 | 9,951.89 | 62.52 | 1,346.30 | 10.64 | 146 | 13.28 | 48.25 | |
455.10 | 7,243.45 | 56.03 | 702.20 | 20.80 | 91 | 81.06 | 50.65 | |
496.10 | 4,977.90 | 73.38 | 769.90 | 33.97 | 67 | - | 58.18 | |
731.35 | 2,372.40 | 28.76 | 742.70 | 16.70 | 78 | 22.45 | 44.72 | |
274.90 | 1,431.70 | 44.86 | 255.90 | 15.11 | 31 | -13.73 | 47.01 | |
1,461.85 | 1,254.66 | 25.90 | 111.60 | 28.72 | 48 | 0.67 | 58.37 | |
564.50 | 1,103.16 | #1 23.91 | 147.80 | #1 134.60 | 19 | #1 760.87 | 46.88 | |
320.85 | 1,020.64 | -113.25 | 1,170.80 | -18.47 | -134 | 90.05 | 63.34 |
Growth Rate
Revenue Growth
4.75 %
Net Income Growth
28.00 %
Cash Flow Change
-132.88 %
ROE
-14.83 %
ROCE
-0.58 %
EBITDA Margin (Avg.)
16.60 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 58 | 61 | 82 | 98 |
| Fixed Assets | 15 | 19 | 22 | 21 |
| Current Assets | 32 | 26 | 53 | 67 |
| Capital Work in Progress | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 43 | 42 | 60 | 77 |
| Total Liabilities | 58 | 61 | 82 | 98 |
| Current Liabilities | 21 | 26 | 33 | 34 |
| Non Current Liabilities | 19 | 16 | 18 | 17 |
| Total Equity | 18 | 19 | 31 | 47 |
| Reserve & Surplus | 17 | 17 | 30 | 34 |
| Share Capital | 2 | 2 | 2 | 14 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 3 | -7 | 13 | -10 |
| Investing Activities | -4 | -7 | -7 | -4 |
| Operating Activities | 14 | 5 | 18 | -6 |
| Financing Activities | -7 | -5 | 2 | -0 |
Share Holding
| % Holding | Mar 2025 | Aug 2025 | Sept 2025 |
| Promoter | 100.00 % | 71.92 % | 71.92 % |
| FIIs | 0.00 % | 1.18 % | 1.37 % |
| DIIs | 0.00 % | 11.44 % | 9.33 % |
| Government | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 11.01 % | 12.30 % |
| Others | 0.00 % | 4.46 % | 5.08 % |
| No of Share Holders | 7 | 7 | 779 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 13 Nov 2025 |  Quarterly Result Announcement | NA | 13 Nov 2025 | 147.90 | 141.50 |
Announcements
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Acceptance Of Request For Providing Credit/Cashless Medical Services To All Serving Officer(S)/Official(S) Of The Supreme Court Of India
2 days ago
2 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20184 days ago
4 days agoIntimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Empanelment With WDRA Government Of India7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Monitoring Agency ReportNov 13, 2025
Nov 13, 2025Unaudited (Standalone And Consolidated) Financial Results Of The Company For Half Year Ended 30Th September 2025Nov 13, 2025
Nov 13, 2025Board Meeting Outcome for Unaudited Financial Result (Standalone And Consolidated) For Half Year Ended 30Th September 2025Nov 13, 2025
Nov 13, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 12, 2025
Nov 12, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Nov 11, 2025
Nov 11, 2025Board Meeting Intimation for To Consider And Approve Unaudited (Standalone And Consolidated) Financial Results Of The Company For The Half Year Ended September 30 2025Nov 04, 2025
Nov 04, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Oct 07, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Monday 15 September 2025Sep 15, 2025
Sep 15, 2025Intimation For Change Of Corporate Identification Number (CIN) And Listing Status Of Star Imaging And Path Lab LimitedSep 04, 2025
Sep 04, 2025Listing of Equity Shares of Star Imaging And Path Lab LtdAug 18, 2025
Aug 18, 2025Technical Indicators
RSI(14)
Neutral 22.99
ATR(14)
Less Volatile 4.90
STOCH(9,6)
Neutral 25.44
STOCH RSI(14)
Neutral 60.04
MACD(12,26)
Bullish 0.40
ADX(14)
Strong Trend 46.94
UO(9)
Bearish 46.35
ROC(12)
Downtrend And Accelerating -10.74
WillR(14)
Neutral -79.21
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
